Kh. Park et al., TELOMERASE ACTIVITY AND TELOMERE LENGTHS IN VARIOUS CELL-LINES - CHANGES OF TELOMERASE ACTIVITY CAN BE ANOTHER METHOD FOR CHEMOSENSITIVITY EVALUATION, International journal of oncology, 13(3), 1998, pp. 489-495
For the cancer cells which have overcome the second mitotic clock (M2)
, activated telomerase is essential and used as another marker of immo
rtality. Many trials had been initiated to target telomerase, which is
known to be specific to tumors. To determine the best in vitro cell s
ystem for testing the efficacy of telomerase inhibitors, we evaluated
the telomerase activity of various cancer cell lines and measured thei
r telomere lengths. We also treated some cancer cell lines with adriam
ycin and measured the changes of telomerase activity. Telomerase activ
ity was evaluated in various cell lines with the TRAP (telomeric repea
t amplification protocol) assay. Telomerase activity was calculated an
d translated into arbitrary units by computer-assisted densitometry wi
th the control of telomerase activity in the 293 control cell line. Al
so, terminal restriction fragment lengths were measured using Southern
blotting. We also measured telomerase activity and telomere lengths i
n 11 benign breast tumor tissues and 19 paired stomach cancer and norm
al tissues. Cancer cell lines treated with adriamycin we evaluated for
changes of telomerase activity and the cell proliferation by MTT assa
y and dye exclusion test. Telomerase activity of cell lines was 95.3+/
-24.1 unit with a range of 27.6-129.6 unit, while the telomere lengths
of those cell lines were variable from 5.0 to 10.4 kbp with a median
of 6 kbp. In 11 cancer cell lines which were not yet firmly establishe
d, we could not detect any telomerase activity. Low telomerase activit
y was detected in only 2 benign tumor tissues of breast with a median
telomere length of 8.8 (7-10.5) kbp. Among paired 19 gastric cancer an
d normal tissues, only 7 cancer tissues showed weak telomerase activit
y. After adriamycin treatment, telomerase activity in YCC-S-1, YCC-S-3
, MCF-7 and MCF-7/ADR was decreased in accordance with the changes of
the cell numbers. Telomerase is specific to cancer tissues and is expr
essed differently from organ to organ. Telomerase activity by TRAP ass
ay could be used as a chemosensitivity assay.